Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Findings from machine learning-based and population-level electronic health record data-based emulation of landmark phase III randomised clinical trials in oncology
Findings from the Beamion LUNG-1 study
The combination is indicated for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma
Evidence for efficacy is based on the results from the MC-FludT.14/L Trial II
Findings from final efficacy and safety analyses from the LIBRETTO-001 study
Findings from a retrospective cohort study
Findings from a global cohort of patients harbouring germline pathogenic/likely pathogenic variants in BRCA1 or BRCA2
New indication concerns treatment of adults with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy
Evidence for efficacy is based on the results from the DESTINY-Breast06 study
Findings from a systematic review of published studies
Findings from the PEACOCC study
Findings from the CEPHEUS study
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
Analytics cookies help us improve our website by collecting and reporting information on its usage.
We use marketing cookies to build a profile of you as a user through your actions on our site in order to better understand your interests and provide you with pertinent suggestions.
